Influenza Vaccination in Patients Living With HIV in the Northern Region

Influenza Vaccination in Patients Living With HIV in the Northern Region: An Observational Monocentre Study of Blankets, Modalities, Drivers and Brakes

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT04402684

Acronym

VACCIGRIPPE

Enrollment

124

Registered

2020-05-27

Start date

2020-04-10

Completion date

2020-12-30

Last updated

2021-01-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

HIV

Brief summary

Anyone living with the Human Immunodeficiency Virus (HIV) has an indication for annual influenza vaccination. (Vaccination schedule and vaccination recommendations 2019). Influenza is a viral infection that has a significant impact on the health care system. However, vaccination coverage in France is still insufficient with regard to the objectives set at 75% by the WHO and the European Commission. For the 2019-2020 seasonal influenza vaccination campaign, flu vaccination by volunteer pharmacists has become possible throughout the country. Studies that have estimated vaccination coverage among HIV-positive populations are rare and show very low rates.

Detailed description

Cross-sectional study via a self-questionnaire given to all HIV-infected patients coming for a scheduled consultation as part of their HIV follow-up in the spring of 2020. Non-opposition letter given to the patient. Collection of data a posteriori from the medical file recorded in the eNadis patient file.

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Any adult person living with HIV presenting for a follow-up consultation in the spring of 2020 * People who do not read French may participate if they wish with the help of a medical or paramedical staff member. * Patient did not object

Exclusion criteria

* Minor patients * Major under guardianship, curatorship, protected person

Design outcomes

Primary

Measure	Time frame	Description
questionnaire influenza vaccine coverage	through study completion, an average of 1 year	The objective of this questionnaire is to estimate the influenza vaccine coverage among PVVIH followed at the Tourcoing Hospital Center.

Secondary

Measure	Time frame	Description
modalities of influenza vaccination	through study completion, an average of 1 year	To identify the modalities of influenza vaccination when it is carried out
the drivers and disincentives to influenza vaccination	through study completion, an average of 1 year	Estimate from patient reports the drivers and disincentives to influenza vaccination in a specific risk population.

Countries

France

Outcome results